Margarita Navarro Pérez

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology

Vall Hebron Institut de Recerca

Margarita Navarro Pérez

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology

Vall Hebron Institut de Recerca

Related news

A questionnaire and self-administered tests detect the progression of multiple sclerosis

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Dr. Xavier Montalban, Dr. Mar Tintoré and Dr. René Carvajal

Age and treatment may predict risk of multiple sclerosis reactivation

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

Viva in Vitro and Vall d’Hebron will study biomarkers in multiple sclerosis

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.